HempFusion Wellness Announces Toxicology Results from Validcare's Clinical Study on CBD Liver Safety Biotech Investing
NOTICE FROM FIRM THAT FILED THE LAWSUIT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
MagicMed CEO Dr. Joseph Tucker: Artificial Intelligence in the Psychedelics Sector Pharmaceutical Investing
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of BELLUS Health Inc. Investors Biotech Investing
Lexaria to Present at the Benzinga Biotech Small Cap Conference on March 24, 2021 at 9:45 AM ET Biotech Investing
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
BLU INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BELLUS Health, Inc. Biotech Investing
MagicMed’s Natalie Dolphin: PsyAI™ Designed to Streamline Pharmaceutical Design Pharmaceutical Investing
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against BELLUS Health Inc. Biotech Investing
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BELLUS Health Inc. Investors Biotech Investing
